Neoplasms, Multiple Primary: Clinical Trials

2 trials for Neoplasms, Multiple Primary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 1, Terminated 1

Follow Neoplasms, Multiple Primary: new trials by email Literature Review of Neoplasms, Multiple Primary trials Research Report on Neoplasms, Multiple Primary

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
Computed Tomography, Gallium Ga 68-Edotreotide, Positron Emission Tomography - Meningioma, Metastatic Well Differentiated Neuroendocrine Neoplasm
Early Phase 1TerminatedM.D. Anderson Cancer Center42017-05-162021-02-15
Degradation of the Anorexic Hormone Peptide YY
PYY1-36 infusion, PYY1-36 + sitagliptin, PYY3-36 infusion - Healthy
Early Phase 1CompletedHvidovre University Hospital82014-05-012015-07-10

Narrower conditions

Multiple Endocrine Neoplasia Type 1 (2)  ·  Meningioma (1)  ·  Neuroendocrine Tumors (1)  ·  von Hippel-Lindau Disease (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Multiple Endocrine Neoplasia (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Neoplastic Syndromes, Hereditary (2)  ·  Abnormalities, Multiple (1)  ·  Angiomatosis (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Ciliopathies (1)  ·  Congenital Abnormalities (1)

Interventions

Magnetic Resonance Spectroscopy (1)  ·  Sitagliptin Phosphate (1)  ·  gallium Ga 68 dotatate (1)

Sponsors

Hvidovre University Hospital (1)  ·  M.D. Anderson Cancer Center (1)

Countries

Denmark (1)  ·  United States (1)

Top investigators

Homer A Macapinlac, MD (1)